Skip to content

Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00157144
Enrollment
Unknown
Registered
2005-09-12
Start date
2004-10-31
Completion date
2006-08-31
Last updated
2014-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Distress Syndrome, Adult, Respiratory Insufficiency, Shock, Cardiogenic

Keywords

Lung Transplantation, Heart Transplantation

Brief summary

Extracorporeal membrane oxygenation (ECMO) is a means of artificially performing the function of the human lung and/or heart outside the body. Its use is escalating in a wide range of clinical settings in the adult population without evidence or guidelines to support this practice. This study involves a nationwide questionnaire which has two components. The initial pilot survey will attempt to identify all institutions currently practicing ECMO or those intending to do so in the future, and are willing to participate in prospective data collection. The second phase will involve a monthly survey of these centres regarding the extent of ECMO use, practice details implemented, and outcome data. It is hoped that the collection of this information will later assist in the development of guidelines for this expensive and presently unsubstantiated practice, together with the construction of appropriate training programs for staff.

Interventions

None listed

Sponsors

Bayside Health
Lead SponsorOTHER_GOV

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients receiving ECMO in Australia and New Zealand

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 5, 2026